Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia. - Guarini A; Radice G; Peragine N; Buracchi C; De Propris MS; Di Rocco A; Chiaretti S; Moretti A; Napolitano S; Martelli M; Balduzzi A; Gaipa G; et al. (Cancers, 2023)